Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection

Journal of Clinical Microbiology

Volumn 46, Issue 4, 2008, Pages 1501-1503

  Vermitsky, John Paul ^a   Self, Matthew J ^a   Chadwick, Sean G ^a   Trama, Jason P ^a   Adelson, Martin E ^a   Mordechai, Eli ^a   Gygax, Scott E ^a,b  

^a LLC   (United States)

^b Research and Development Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORIC ACID; FLUCYTOSINE; PYRROLE DERIVATIVE; FUNGAL DNA;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; FEMALE; FUNGAL DETECTION; FUNGUS ISOLATION; GROUPS BY AGE; HEALTH SURVEY; HUMAN; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SPECIES DISTRIBUTION; UTERINE CERVIX CYTOLOGY; VAGINA FLORA; VULVOVAGINITIS; WOMEN'S HEALTH; AGE; CANDIDA; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; SPECIES DIFFERENCE; UNITED STATES; UTERINE CERVIX; VAGINA; VAGINA CANDIDIASIS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

ADULT; AGE FACTORS; AGED; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CERVIX UTERI; DNA, FUNGAL; FEMALE; HUMANS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; UNITED STATES; VAGINA;

EID: 42449106925     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02485-07     Document Type: Article

References (16)

1. Arthington-Skaggs, B. A., W. Lee-Wang, M. A. Ciblak, J. P. Frade, M. E. Brandt, R. A. Hajjeh, L. H. Harrison, A. N. Sofair, and D. W. Warnock. 2002. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantification method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob. Agents Chemother. 46:2477-2481.
2. Bader, M. S., S. M. Lai, V. Kumar, and D. Hinthorn. 2004. Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality. Scand. J. Infect. Dis. 36:860-864.
3. Chou, H.-H., H.-J. Lo, K.-W. Chen, M.-H. Liao, and S.-Y. Li. 2007. Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn. Microbiol. Infect. Dis. 58:427-433.
4. Dan, M., R. Segal, V. Marder, and A. Leibovitz. 2006. Candida colonization of the vagina in elderly residents of a long-term-care hospital. Eur. J. Clin. Microbiol. Infect. Dis. 25:394-396.
5. Fidel, P. L., and J. D. Sobel. 1996. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev. 9:335-348.
6. Goswami, D., R. Goswami, U. Banerjee, V. Dadhwal, S. Miglani, A. A. Lattif, and N. Kochupillai. 2006. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole. J. Infect. 52:111-117.
7. Nyirjesy, P., S. M. Seney, M. H. T. Grody, C. A. Jordan, and H. R. Buckley. 1995. Chronic fungal vaginitis: the value of cultures. Am. J. Obstet. Gynecol. 173:820-823.
8. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Harold, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother 47:3149-3154.
9. Ozcan, S. K., F. Budak, G. Yucesoy, S. Susever, and A. Willke. 2006. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. APMIS 114:139-145.
10. Paulitsch, A., W. Weger, G. Ginter-Hanselmayer, E. Marth, and W. Buzina. 2006. A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria. Mycoses 49:471-475.
11. Ray, D., R. Goswami, U. Banerjee, V. Dadhwal, D. Goswami, P. Mandal, V. Sreenivas, and N. Kochupillai. 2007. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30:312-317.
12. Redding, S. W., W. R. Kirkpatrick, S. Saville, B. J. Coco, W. White, A. Fothergill, M. Rinaldi, T. Eng, T. F. Patterson, and J. Lopez-Ribot. 2003. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J. Clin. Microbiol. 41:619-622.
13. Richter, S. S., R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 43:2155-2162.
14. Safdar, A., D. Armstrong, E. W. Cross, and D. S. Perlin. 2002. Prospective epidemiologic analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center. Int. J. Infect. Dis. 6:198-201.
15. Sanglard, D., F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
16. Vermitsky, J.-P., and T. D. Edlind. 2004. Azole resistance in Candida glabrata: coordinate upregulatioin of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 48:3773-3781.